Income Statement
ESPERION THERAPEUTICS, INC.
ESPR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
403.14 | 332.31 | 116.33 | 75.48 | 78.45 | 227.55 | 148.40 | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
403.14 | 332.31 | 116.33 | 75.48 | 78.45 | 227.55 | 148.40 | - | - | - | - | - | - |
|
Operating Expenses
|
342.86 | 277.91 | 271.90 | 254.98 | 305.18 | 348.94 | 241.47 | 204.59 | 168.98 | 76.15 | 50.04 | 36.22 | 22.76 |
|
Research & Development
|
47.85 | 46.24 | 86.11 | 118.93 | 105.98 | 146.94 | 175.61 | 171.49 | 147.60 | 57.87 | 29.80 | 25.30 | 16.01 |
|
Selling, General & Administrative
|
165.79 | 163.07 | 142.52 | 109.08 | 184.99 | 199.62 | 65.85 | 33.10 | 21.38 | 18.28 | 20.24 | 10.92 | 6.74 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
60.27 | 54.40 | -155.56 | -179.50 | -226.73 | -121.40 | -93.07 | -204.59 | -168.98 | -76.15 | -50.04 | -36.22 | -22.76 |
|
Non-Operating Income
|
81.11 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Income
|
3.50 | 7.60 | 4.40 | 2.40 | 0.10 | 0.50 | 3.70 | 2.60 | - | - | - | - | - |
|
Interest Expense
|
18.90 | 12.00 | 58.98 | 56.81 | 46.35 | 22.67 | 8.12 | 0.10 | 0.20 | 0.40 | 0.52 | 0.30 | 0.94 |
|
Other Non-Op Income / Expense
|
3.49 | 8.02 | 5.29 | 2.65 | 3.98 | 0.52 | 4.06 | 2.78 | 2.19 | 1.55 | 0.78 | 0.12 | 0.19 |
|
Income Before Tax
|
-20.84 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
1.84 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-22.68 | -51.75 | -209.25 | -233.66 | -269.11 | -143.55 | -97.17 | -201.81 | -166.99 | -74.98 | -49.78 | -36.38 | -26.09 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
60.27 | 54.40 | -155.56 | -179.50 | -226.73 | -121.40 | -93.07 | -204.59 | -168.98 | -76.15 | -50.04 | -36.22 | -22.76 |
|
Earnings Per Share (Basic)
|
-0.11 | -0.28 | -2.03 | -3.52 | -9.31 | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.11 | -0.28 | -2.03 | -3.52 | -9.31 | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
207.87 | 187.18 | 103.11 | 66.41 | 28.90 | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
207.87 | 187.18 | 103.11 | 66.41 | 28.90 | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-22.68 | -51.75 | -209.25 | -233.63 | -269.14 | -143.57 | -96.82 | -201.28 | -167.66 | -74.67 | -50.21 | -36.43 | -26.09 |